You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Aminosyn Ii 4.25% In Dextrose 20% In Plastic Container patents expire, and when can generic versions of Aminosyn Ii 4.25% In Dextrose 20% In Plastic Container launch?

Aminosyn Ii 4.25% In Dextrose 20% In Plastic Container is a drug marketed by Abbott, Hospira, and Hospira Inc. and is included in four NDAs.

The generic ingredient in AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER is amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride profile page.

Summary for AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
Drug patent expirations by year for AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER
Anatomical Therapeutic Chemical (ATC) Classes for AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER

US Patents and Regulatory Information for AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.